The invention relates to a solid dosage form preparation which comprises a dihydropyridines calcium antagonist such as lercanidipine in a therapeutically effective amount or salts thereof as well as colloidal silicon dioxide such as Aerosil TM used for improving the bioavailability and improving the solubility. The invention also relates to a method for preparing the solid dosage form preparation through wet granulation.